Salt CompositionYou Searched
Lorax 3 Tablet
Consern Pharma Ltd.
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Short term anxiety / Treatment of Anxiety disorder
Customers also bought
More About Lorax
Benefits
In Treatment of Short term anxiety Lorax 3 Tablet reduces the symptoms of excessive anxiety and worry that may arise in stressful conditions such as an exam or job interview. It can also reduce feelings of restlessness, tiredness, difficulty concentrating and feeling irritable. This will therefore help you go about your daily activities more easily and be more productive. Keep taking this medicine even if you feel well. Stopping suddenly can cause serious problems. In Treatment of Anxiety disorder Lorax 3 Tablet helps relieve symptoms of many anxiety disorders including obsessive-compulsive disorder and generalised anxiety disorder by increasing the level of a chemical called GABA in your brain. This prevents abnormal symptoms of anxiety such as restlessness, tiredness, difficulty concentrating, feeling irritable and sleep problems. It helps you feel calm with a better ability to deal with problems. Exercise and a healthy diet can also improve your mood. Keep taking the medicine until your doctor advises you to stop.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Lorax 3 Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Lorax 3 Tablet is a benzodiazepine. It works by increasing the action of a chemical messenger (GABA) which suppresses the abnormal and excessive activity of the nerve cells in the brain.
Unsafe: Avoid consuming alcohol with Lorax 3 Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Lorax 3 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Seek medical advice from your doctor: Lorax 3 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Lorax 3 Tablet should be used for short periods and sleepiness of the baby should be watched. The withdrawal of Lorax 3 Tablet should be gradual.
Not Safe: Lorax 3 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Caution Advised: Lorax 3 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Lorax 3 Tablet may be needed. Doctor consultation is advised. However, inform your doctor if you have any underlying kidney disease.
Caution Advised: Lorax 3 Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Lorax 3 Tablet may be needed. Doctor consultation is advised. Use of Lorax 3 Tablet is not recommended in patients with severe liver disease.
What if I forget to take it?
If a dose of Lorax 3 Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Consern Pharma Private Limited, Kuljive Mahajan(Mg. Director), Rural Focal Point, V.P.O. Tibba, Ludhiana - 141120, Punjab, India
References
Stahl SM, editor. Lorazepam. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 367-71
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 819-20
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (20 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (25 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
